News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Mark Terry

news@biospace.com

BioSpace News - By Mark Terry
Shire (SHPG) Terminates a Couple of Biosimilar Deals Made by Baxalta (BXLT) 9/27/2016
Amgen (AMGN) Waves Golden Tickets at Biotech Startups for Kendall Square Space 9/27/2016
3 Biotechs With Key Decisions Pending in the Next 18 Months 9/27/2016
A Look at What's Next for Pfizer (PFE), More Acquisitions Could Come 9/27/2016
Cancer Immunotherapy Startup Fortis Therapeutics Launches With $18 Million Series A 9/27/2016
Meet the Rock Star Scientist Who's Spending Facebook's CEO and Wife's $3 Billion 9/26/2016
Two Promising Biotech Stocks Under $5, and One to Avoid Like the Plague 9/26/2016
It’s Official! No Divorce for Pfizer (PFE)'s Two Units 9/26/2016
PerkinElmer (PKI) Reorganizes and Splits Into Two Business Segments 9/26/2016
New Setback Increases Sanofi (SNY)'s Hunger for a M&A 9/26/2016
Speculation Mounts Over an Allergan (AGN)-Gilead (GILD) Mega Deal 9/26/2016
Biotech vs. Big Pharma: Which is the Better Place to Work? 9/26/2016
Saga Continues for Sarepta (SRPT) as FDA Head Calls for Retraction of 'Misleading' 2013 Study 9/23/2016
This Biotech Has the Upper Hand Over Allergan (AGN) and Gilead (GILD) in the Heated Nash Battle 9/23/2016
This Little Biotech Could be a New Acquisition Target for Allergan (AGN) and Biogen (BIIB) 9/23/2016
Investors Beware: Thin CAR-T Data Could Make or Break Juno (JUNO) and Kite Pharma (KITE) 9/23/2016
AstraZeneca PLC (AZN) to Shutter Pennsylvania Office, 134 Employees Affected 9/23/2016
Facebook CEO Zuckerberg and Wife Chan Set Up New Bay Area Biohub With $3 Billion Investment to Cure All Diseases 9/23/2016
Genentech (RHHBY) Gambles $310 Million+ on German Biotech BioNTech's mRNA Cancer Vaccine Tech 9/23/2016
4 Biotechs Gilead (GILD) Could Be Targeting After Losing Medivation (MDVN) 9/22/2016
Bayer (BAY)’s Dermatology Unit Sale Said to Attract Teva (TEVA) and Perrigo (PRGO) 9/22/2016
Continuing Its String of Deals, Allergan (AGN) Buys Bay Area’s Tobira (TBRA) for $1.695 Billion 9/21/2016
The Power of Three: Sarepta (SRPT) to Open New Plant, Hire Staff and Confirms Kaye as CEO 9/21/2016
Iroko Pharma Slashes a Quarter of Workforce, But Plans to Hire 90 Sales Reps 9/21/2016
Meet the Powerful Woman Behind the Scenes of Sarepta (SRPT)'s DMD Drug Approval 9/21/2016
The Drugmaker That Could Knock Gilead (GILD) Off Its HIV Throne 9/20/2016
How Ionis Pharma (IONS) is Beating the Pants Off of Competitors Like Alnylam (ALNY), Arrowhead Pharma (ARWR) and Moderna 9/20/2016
Will Biogen (BIIB)’s Alzheimer’s Drug Be a Miracle Drug or Just Another Bomb? 9/20/2016
FDA Places Clinical Hold on AML Drug Co-Developed by Johnson & Johnson (JNJ) and Genmab A/S (GEN.CO) 9/20/2016
Victory at Last! Sarepta (SRPT) Stock Doubles as the FDA Finally Approves DMD Drug 9/20/2016
Everybody's Talkin' About New Houston Biotech Startup Cellenkos 9/20/2016
M&A Bonanza Continues as Johnson & Johnson (JNJ) Pays $4.325 Billion for Abbott (ABT)'s Eye Surgery Biz 9/19/2016
4 Precious Cannabis-Based Biotechs are Potential Takeover Targets 9/19/2016
Pfizer (PFE) May No Longer Need to Split Post-Medivation (MDVN) 9/19/2016
Eisai Company (ESALY.PK) Launches Ambitious 90-Scientist Collaborative R&D Unit in Boston Area 9/16/2016
SoCal's Aerie (AERI) Stock Soars Over the Rainbow on Positive Phase III Eye Drug Data 9/16/2016
What's PARP? Meet Two of Biotech's Newest M&A Targets: Tesaro (TSRO) and Clovis Oncology (CLVS) 9/16/2016
Gilead (GILD) to Release Data on 9 Clinical Trials Before End of the Year 9/16/2016
Bay Area's Rigel (RIGL) Slashes 38% of Workforce; Shifts From R&D to Commercial Operation 9/16/2016
Bay Area Depomed (DEPO) Rumored to be Putting Itself Up for Sale (Once Again) 9/16/2016
Regeneron (REGN) Plans to Double R&D Space With 1 Million Square Feet of Additions 9/15/2016
Let's Hear It for the Yale Professor Who Launched New Biotech Kleo 9/15/2016
Born to Be Wild: Relay Therapeutics Launches With $57 Million to Make Movies of Cell Proteins 9/15/2016
Why Gilead (GILD) Should Think About Wooing Massachusetts' Tesaro (TSRO) 9/15/2016
Turn the Page: Sarepta (SRPT) Stock Pops on Rumors DMD Drug Naysayer Leaves the FDA 9/15/2016
With R&D Ops in the Bay Area, Cambridge Startup Delinia Launches With $35 Million and Plans to Start Hiring 9/14/2016
These are the Days of Moderna's Lives: Behind the Curtain of One of the Most Mysterious Biotechs 9/14/2016
The 3 Most-Coveted Cancer Acquisition Targets Post-Medivation (MDVN) 9/14/2016
Never Say Never: Why Gilead (GILD) Could be a Takeover Target 9/14/2016
Everything's Bigger in Texas: Aeglea (AGLE) Quickly Growing into Leading Austin Biotech 9/14/2016
There's No Place Like Massachusetts for China's Largest Biotech Vcanbio 9/14/2016
Will FDA’s Scrutiny of Pfizer (PFE)’s Chantix Trial Go Up in Smoke? 9/13/2016
Alphabet's Verily, Sanofi (SNY) Launch $500 Million Onduo, Joint Venture to Open New HQ in Kendall Square 9/13/2016
10 Biotechs—Count ‘Em, 10!—With Big Decisions in the Fourth Quarter 9/13/2016
Gene Editing Phenom CRISPR Files for $90 Million IPO 9/12/2016
Cha-Ching...5 Boston Area Companies That Cashed in Big This Week 9/12/2016
Home Sweet Home: 11 Biotech Startups Land New Digs at Harvard Life Lab 9/12/2016
Why People Are Angry at This Wells Fargo Ad About Scientists 9/9/2016
Meet the Next Wave of Scientists Who Are Taking Over Biotech 9/9/2016
Investors: Here's What You Need to Know About Gilead (GILD) and Roche (RHHBY) 9/9/2016
Ooh...Pfizer (PFE) Did it Again, Ties It Up With a Startup and Spinout 9/9/2016
Bay Area's Catalyst Biosciences Halves Workforce to Focus on Clinical Hemostasis Programs 9/8/2016
With $1.4 Billion in Cash, Booming Moderna Plans to Hire 100 and Drops $100 Million on New Manufacturing Facility 9/8/2016
GW Pharma (GWPH) Stock Pops on Buyout Chatter 9/8/2016
Taking a Look at 3 Stocks That are Better Buys Than Gilead (GILD) 9/8/2016
Another Celgene (CELG) Bet Pays Off as Agios (AGIO) Eyes Early Approval of Leukemia Drug 9/8/2016
Cancer Drug Developed by Eliza Hall Institute, AbbVie (ABBV) and Genentech (RHHBY) “Melts Away Cancer” 9/7/2016
Investors Wait Patiently for Gilead (GILD) and Its CEO to Make a M&A for Growth and to Get Out of Share Slump 9/7/2016
NeuroPhage Transforms Into Proclara, Bags $47 Million and and Launches Phase Ib Alzheimer’s Trial 9/7/2016
Is 180 Medical Even Buyout Worthy? 9/7/2016
SEC Filings Show How Medivation (MDVN)’s CEO and Board Backroom Dealings Drove Up Acquisition Price 9/7/2016
Falcon Genomics Bankruptcy Underlines Pittsburgh Venture Capital Weakness 9/7/2016
How the Bay Area is Still King of Biotech 9/7/2016
September is a Busy Month for 7 Biotechs 9/6/2016
Aduro Biotech (ADRO) Opens New HQ in the Bay Area, Eventually to House 400 Workers 9/6/2016
Arena (ARNA) Forms Drug Discovery Incubator Beacon Discovery 9/2/2016
Why Cytokinetics (CYTK) Stock Dropped on the Good News of an Upcoming Phase III Trial 9/2/2016
Layoffs are Underway as Teva (TEVA) Winds Down Operations at New York Plant 9/2/2016
Genentech (RHHBY)'s Tecentriq Shows Positive Data in Phase III Trial, Has an Upcoming Action Date in October 9/2/2016
Among Global Challenges, Novo Nordisk A/S (NVO)’s CEO Steps Down, Executive Team is Shuffled 9/1/2016
3 Biotechs Expecting to Release Clinical Trial Data Soon 9/1/2016
SEC Docs Say Pfizer (PFE) Beat Out 4 Companies to Buy Medivation (MDVN) 9/1/2016
Athenex Looking Elsewhere as State Lags on Plans for Cancer Drug Plant 8/31/2016
Key Parkinson's Trial Delayed Due to Feud Between a Georgetown University Scientist and The Michael J. Fox Foundation 8/31/2016
3 Potential Juicy Biotech Acquisition Targets 8/31/2016
2 High-Risk Biotechs Ready to Rock—Maybe 8/31/2016
CRO AMRI (AMRI) Restructures and Cuts Jobs as Result of Euticals Acquisition 8/31/2016
Stock Pops as Medivir (MVRBF) Decides to Split into Two Companies 8/31/2016
What You Don't Know: Pfizer (PFE)’s Connection to Mylan (MYL) and EpiPen 8/31/2016
Why 3 Billionaires Ditched Johnson & Johnson (JNJ) Stock 8/30/2016
Biotechs are Expanding in the Bay Area Again: Bristol-Myers Squibb (BMY), Genentech (RHHBY), Gilead (GILD), Illumina (ILMN) and Verily and More 8/30/2016
AstraZeneca PLC (AZN) Puts 'For Sale' Sign on U.S. HQ 8/29/2016
AxoSim Leads a Biotech Startup Scene in New Orleans 8/29/2016
Mylan (MYL) Isn't Alone: 11 Drug Companies With Muscular Pricing Power and Staggering Profit Margins 8/26/2016
Embattled Theranos Plans to Appeal to Re-Open Its Lab in Newark, California 8/26/2016
Amidst Dramatic Reorganization, Takeda (TKPYY) May (Or May Not) Shutter Cambridge, UK Site 8/26/2016
How Pfizer (PFE)’s Antibiotics Buy from AstraZeneca PLC (AZN) Will Affect Jobs in the U.S. 8/26/2016
Led by Former Genentech (RHHBY) Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships 8/26/2016
Just Days after a $14 Billion Medivation (MDVN) Buy, Pfizer (PFE) Buys AstraZeneca PLC (AZN)'s Antibiotics Business for $1.5 Billion-Plus 8/26/2016
Medivation (MDVN) Exec Jumps Ship to Become CMO at BeiGene (BGNE) 8/26/2016
Amgen (AMGN) Remains Hush-Hush Over FDA Rejection of Parsabiv 8/25/2016
These Biotech Employers Hired the Most New Grads In Life Sciences 8/25/2016
3 High-Risk, High-Reward Biotech Stocks 8/25/2016
Affiliate of Amethyst Tech, Advent Laboratories, to Move to Western Maryland and Create 20 Jobs 8/24/2016
Bay Area's AllCells to Open Up Shop in Boston 8/24/2016
Celgene (CELG)'s Once-Nightmare Drug Turned Blockbuster Returns 8/24/2016
6 Hot Biotech Acquisition Targets 8/23/2016
SoCal's Sophiris Bio (SPHS) Evaluating Options, Will Not Pursue New Clinical Trials Unless New Financing is Obtained 8/23/2016
A Look at the Winners and Losers of Medivation (MDVN)'s $14 Billion Pfizer (PFE) Buyout Deal 8/23/2016
Pfizer (PFE) Scoops Sanofi (SNY) With $14 Billion Buyout Deal for Medivation (MDVN) 8/23/2016
Active Pharmaceutical Ingredient Maker Lonza Biologics (LONN.VX) to Hire 70 in New Hampshire 8/22/2016
Bayer (BAY) and CRISPR Form 80 Employee Joint Venture Named Casebia Therapeutics in Boston Area 8/22/2016
After Kendall Square Success, Alexandria Real Estate Equities Aims to Create Another Biotech Mecca in Massachusetts 8/22/2016
3 CEOs With the Biggest Golden Parachutes in Life Science 8/19/2016
Sarepta (SRPT)’s Duchene Muscular Dystrophy Drug: Evaluating the Placebo Effect 8/19/2016
Google (GOOG)'s Calico Hires Another Big Name in Quest to Unlock Healthy Aging 8/19/2016
Bay Area's Portola (PTLA) Plummets as FDA Rejects AndexXa NDA 8/19/2016
StemCells (STEM) CEO, CFO and Three Directors Stepped Down the Day of Microbot Merger That Boosted Stock Sevenfold 8/18/2016
Merck & Co. (MRK)'s Sale of Legacy Products in India Hints at Restructuring 8/18/2016
Former BIND Therapeutics (BIND) CEO Joins Agios (AGIO) as New CFO 8/17/2016
Cincinnati CRO CTI - Clinical Trial and Consulting Services Moves HQ to Kentucky and Promises 500 New Jobs over 12 Years 8/17/2016
Activist Investor Jeffrey Smith Wants to Overturn Depomed (DEPO) Board and Run it Like Olive Garden 8/17/2016
Tioma, Originally Founded as Vasculox, Scores $86 Million Series A Financing 8/16/2016
4 Cheap Biotech Stocks Ready to Fly 8/16/2016
A Gilead (GILD) and Bristol-Myers Squibb (BMY) Merger—Let Us Count the Ways 8/16/2016
Anavex (AVXL)'s Puzzling Business Problems 8/16/2016
Billionaire Hedge Fund Manager Increases Stake in Allergan (AGN), Cuts Back on Energy Bets 8/16/2016
As Baxalta (BXLT) Merger Closes, Shire (SHPG) Talks Job Cuts Worth $700 Million 8/15/2016
Up-and-Coming AxoSim Hiring Scientists After Landing Research Grants to Speed Research 8/15/2016
Pfizer (PFE) Goes Full Steam Ahead With Its Acquire-to-Expand Strategy, Big Buy Could Prevent a Split 8/15/2016
Serial Biotech Entrepreneur Raises Money to Launch New Startup DMD Therapeutics 8/15/2016
Apples to Apples: Comparing EXACT Sciences (EXAS) to Myriad Genetics (MYGN) 8/15/2016
Biotech Startup Practichem Is Buying Tesla Cars for Its Employees 8/15/2016
Radius Health (RDUS) May Be Acquisition Target for Shire (SHPG) Based on Its Osteoporosis Pipeline 8/12/2016
6 Biopharma Stocks Under $10 Per Share Expected to Climb 8/12/2016
AbSci’s Change in Strategy Scuttles Vancouver’s Plans for a Biotech Hub 8/12/2016
After a Dazzling Second Quarter, Amgen (AMGN) Develops Strategy to Deal With Upcoming Biosimilar Competition 8/11/2016
Allergan (AGN) to Consolidate Four New Jersey Locations Into One New U.S. HQ in Madison; PsychoGenics Also Moving In 8/11/2016
3 High-Risk, Potentially High-Reward Biotech Stocks 8/11/2016
French Government Denies Cover-Up of Birth Defects Study Related to Sanofi (SNY) Epilepsy Drug 8/11/2016
12-Employee Lexington Biotech, Aldeyra (ALDX) Shows Off Positive Drug Trial Data 8/10/2016
Allergan (AGN)'s Brent Saunders Denies Interest in Biogen (BIIB) or Big M&A 8/10/2016
San Diego's MEI Pharma (MEIP) Bags Cancer Deal Worth $464 Million With Helsinn 8/9/2016
Takeover Rumors Swirl Again as AstraZeneca PLC (AZN) Stock Hits Pfizer (PFE)'s 2014 Bid Price 8/9/2016
New York City Struggles To Compete With Cambridge and Bay Area for Life Science Startup Support 8/9/2016
Paul Singer’s Hedge Fund Sues AbbVie (ABBV) Over Failed 2014 Shire (SHPG) Merger 8/9/2016
Momenta (MNTA) Stock Jumps at Good News/Bad News—Buyout Rumors and Failed Trial 8/8/2016
Valeant (VRX)'s Constipation Drug Relistor Attracts Interest From Rivals, Sale Could Bring In $400-$500 Million 8/8/2016
Sarepta (SRPT) Stock Surges After Government Website Indicates Firm is Recruiting for Phase III Study 8/5/2016
Despite Skepticism, Biogen (BIIB) Stock Explodes After Merck & Co. (MRK) and Allergan (AGN) Takeover Speculation 8/5/2016
4 Biotech Stocks That Could Triple In Value This Year 8/4/2016
Biogen (BIIB) Not Pursuing an Acquisition, Says Source 8/4/2016
Shire (SHPG) Kills Baxalta (BXLT)'s Hemophilia B Program; Clears Path for BioMarin (BMRN), Spark Therapeutics (ONCE) and uniQure (QURE) 8/4/2016
Pfizer (PFE) Boss Won't Commit to a Company Split, But Decision Might Depend on Whether Clinton or Trump Wins the U.S. Presidential Election 8/3/2016
Speculation Heats Up on Whether a Spin-Off Could be in Gilead (GILD)'s Future 8/3/2016
4 Life Science CEOs Whose Track Records Make All the Difference 8/3/2016
Mass. Startup AVROBIO Rakes in $25 Million Series A to Push Two Gene Therapy Clinical Trials 8/2/2016
AstraZeneca PLC (AZN) CEO Stays Mum as Rumors Swirl Over a Possible Novartis AG (NVS) Takeover Bid 8/2/2016
How BioMarin (BMRN)'s Model for Super-Rare Diseases Made It a $15 Billion Powerhouse 7/29/2016
A Look at Four Biotech Giants' Q2 Earnings 7/29/2016
Brexit Schmexit: What This Mess Means for Life Science Jobs 7/29/2016
AstraZeneca PLC (AZN) Kills Six Pipeline Programs 7/28/2016
Pfizer (PFE) Wins Bid; Buys BIND Therapeutics (BIND) Bankruptcy Assets for $40 Million 7/27/2016
Flushed With Cash, Moderna Expands Space, Went on Hiring Spree and Launches at Least Two Clinical Trials 7/27/2016
Post-Brexit, GlaxoSmithKline (GSK) Eyes Jobs Boost With $360 Million Investment in Three UK Manufacturing Sites 7/27/2016
Why Investors are Still Throwing Cash at Debt-Ridden Kadmon, a NYC Biotech Founded By Ex-Con Sam Waksal 7/26/2016
Speculation Heats Up on Biogen (BIIB) as an Acquisition Target or Starting a Buying Spree 7/26/2016
pSivida (PSDV) Has Its Own Brexit, Consolidates U.K. Operations to Massachusetts HQ 7/26/2016
Bankrupt BIND Therapeutics (BIND) Reveals Two More Bidders Join Pfizer (PFE)'s Stalking Horse Bid 7/26/2016
5 Biotech Stocks on the Brink of Breaking Out 7/25/2016
As Biogen (BIIB) Boss Moves to the Bay Area, California Biotechs Pay Attention 7/25/2016
A Look at Who Could Buy Gilead (GILD) and Who Gilead Should Buy 7/25/2016
3 Battered Biopharma Stocks Battling to Recover 7/22/2016
Why Investors Should Pay Attention to Seattle Genetics (SGEN)' Drug Trial 7/22/2016
Biogen (BIIB) CEO Steps Down Amid Stellar Q2 Financials, Hunt for New Leader Begins 7/22/2016
Amid Trial Concerns, FDA Delays Approval Decision for Merck & Co. (MRK)'s C. Diff Drug, New PDUFA Date Set 7/22/2016
Zafgen (ZFGN) Pinks Slips 34% of Workforce, Scraps Lead Obesity Drug After Deaths 7/21/2016
AstraZeneca PLC (AZN) Announces MedImmune (AZN) Layoffs, But Does Not Specify Numbers or Location 7/21/2016
Johnson & Johnson (JNJ)'s CFO Talks M&A Strategy, Doesn’t Rule Out Acquisitions 7/20/2016
Former bluebird bio (BLUE) CSO Takes the Reins at Oncorus; Startup Launches with $57 Million Series A 7/20/2016
Zafgen (ZFGN)'s Alicia Secor Steps Up as Juniper Pharma (JNP)’s President and CEO 7/20/2016
Cambridge Startup Jounce Lands $2.5 Billion Deal With Biotech's Best Friend Celgene (CELG) 7/20/2016
Bay Area's SciClone (SCLN) Abandons Sale Strategy 7/19/2016
Examining Pfizer (PFE)’s Strategic Options-Split Up or Start Buying 7/19/2016
Why 5 Big Pharma’s Struggle to Please Investors 7/19/2016
3 Biotech Stocks for the Conservative Investor 7/18/2016
Juno (JUNO) Stock Falls Again After Correcting Number of Trial Deaths 7/18/2016
ZIOPHARM Abandons $50 Million Stock Offering After Clinical Trial Deaths 7/18/2016
The ROI of Gratitude: Two Biotechs Getting It Right 7/18/2016
Merck & Co. (MRK) to Cut or Shift 360 East Coast Jobs, Add 100 in the Bay Area 7/15/2016
With a Strong Cancer Presence and Pipeline, Incyte (INCY) Would Make a Sweet Acquisition 7/15/2016
With Little Fanfare, Biogen (BIIB) Sneaks Lupus Drug Into a Phase I Trial 7/15/2016
Former Biogen (BIIB) Exec to Head Decibel Therapeutics, Plans to Fill 20 Jobs This Year, 40 to 60 in 2017 7/14/2016
Life Science Job Market in Washington State Heats Up as Juno (JUNO) and Seattle Genetics (SGEN) Hire 250+ 7/14/2016
Evaluation: 7 Biopharma Companies’ Market Value Based on Pipelines 7/14/2016
Juno (JUNO) Soars After the FDA OKs Restart of Clinical Trial 7/14/2016
Bay Area's Second Genome Taps New CEO, Series B Financing Expanded to $51 Million 7/14/2016
SAGE Therapeutics (SAGE)' Stock Explodes as Drug Eliminates Postpartum Depression in Mid-Stage Study 7/14/2016
Sanofi (SNY) Hunts Other Oncology Companies for Cancer Gold 7/13/2016
San Diego's Sorrento (SRNE) Forges €735 Million Immuno-Onco Tie-Up with Servier 7/12/2016



//-->